TNON Stock Analysis: Buy, Sell, or Hold?
TNON - Tenon Medical, Inc. Common Stock
$0.13
-0.04 (-22.02%)
βΌ
5d:
-33.84%
30d:
-43.17%
90d:
-82.54%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Aug 13, 2026
4d
Get Alerted When TNON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: TNON is down 33.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: TNON is down 33.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TNON is currently trading at $0.13, which is considered oversold relative to its 30-day fair value range of $0.16 to $0.28.
Technical Outlook: Technically, TNON is in a strong downtrend. Immediate support is located at $0.13, while resistance sits at $0.22. Short-term momentum is weak, with the stock down 22.0% recently.
Market Sentiment: TNON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.62 (+1903.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNON is in a strong downtrend. Immediate support is located at $0.13, while resistance sits at $0.22. Short-term momentum is weak, with the stock down 22.0% recently.
Market Sentiment: TNON has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.62 (+1903.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.16 -
$0.28
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-22.0%)
- BULLISH: Trading 1903.8% below Wall St target ($2.62)
- WARNING: Composite score 40/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.16 -
$0.28
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$0.22
Current Trend
Strong Downtrend
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.22
Wall Street Target
$2.63
(+1903.8%)
Revenue Growth (YoY)
89.9%
Profit Margin
-270.1%
Share & Embed Analysis
Last updated: August 08, 2026 5:55 PM ET
Data refreshes hourly during market hours. Next update: 6:55 PM
Data refreshes hourly during market hours. Next update: 6:55 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 32 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 41 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 51 HOLD |
|
ZBH
Zimmer Biomet Holdings I⦠|
HOLD
29 analysts |
$99 | 41 HOLD |